Advancing the Diagnostic-to-Treatment Continuum in Cancer Care –
Detroit

Detroit brings together leading experts in oncology, hematology, pathology, molecular diagnostics, and translational science to explore the rapidly evolving landscape of precision cancer care.

The conference will examine how advances in disease biology, biomarker testing, molecular profiling, and emerging therapies are reshaping diagnosis and treatment across both solid tumors and hematologic malignancies.

Through expert-led presentations, multidisciplinary discussion, and clinically relevant case-based education, the program will highlight evolving approaches in thoracic, breast, genitourinary, gastrointestinal, and hematologic oncology, while exploring the growing role of precision diagnostics in guiding treatment decisions.

Participants will gain practical insights into targeted therapies, immunotherapy, molecular and genomic profiling, liquid biopsy, measurable residual disease (MRD), biomarker-driven treatment selection, and emerging therapeutic strategies – with an emphasis on translating new scientific and diagnostic advances into more informed, individualized patient care.

By bringing together the specialists responsible for diagnosis, molecular characterization, and treatment, the Detroit conference connects pathology and oncology across the full diagnostic-to-treatment continuum – creating a collaborative forum to explore today’s advances and the future direction of precision cancer care.